Thursday, June 7, 2018

MissionIRNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Posts Results of Annual General Meeting

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the results of its annual general and special meeting of shareholders that took place on June 5, 2018. During the meeting, shareholders of the company voted on and approved the following resolutions: re-appointing MNP LLP, Chartered Accountants, as auditor of the company for the 2018 fiscal year; fixing the number of directors of the company at six; the election of directors; the ratification and approval of the company’s 2017 Stock Option Plan; and the approval of a future name change of the company, to be decided by the company’s board of directors. Paul Lucas, Barry Fishman, John Easson, Richard Fitzgerald, Aaron Keay and Daryl Kramp were each elected director at the meeting and will hold office until the next annual meeting of the company or until their earlier resignation or removal. Following the meeting, the board of directors determined to grant 710,000 stock options to certain directors and employees, each of which is exercisable into one common share at an exercise price of $1.39 per share until June 5, 2023. The shares will be subject to a TSX Venture Exchange hold period of four months and one day from the date of grant of the options. The board also approved the grant of 200,000 restricted share units to a director, each of which may be redeemed into one common share once vested on June 5, 2019.
To view the full press release, visit http://ibn.fm/h2h5L
About ABcann Global Corp.
ABcann Global Corporation is committed to becoming a top five cannabis company, recognized for high-quality, trusted and innovative products and services. ABcann holds production and sales licenses from Health Canada. Its flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centered on its specially designed, environmentally-controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products. ABcann is expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, such as Germany, Australia and Israel. For more information, visit www.ABcannGlobal.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html